Reishi Mushroom: Sleep, Immunity and Stress Adaptation

Two Fractions, Two Extractions

The practical importance of reishi's chemistry is that the two active fractions require different extraction methods, and a product using only one will contain only half of what the plant offers.

Beta-glucans are water-soluble polysaccharides that require hot water extraction. They are the fraction responsible for immunomodulation, acting on dectin-1 and complement receptor 3 on immune cells, and they are the basis for the traditional preparation as a decoction.

Triterpenes, including the ganoderic acids, are lipophilic and require alcohol extraction. They account for reishi's characteristic bitterness and have been associated with effects on histamine release, blood pressure, liver protection and the sedative properties reported in animal work.

A dual-extracted product captures both. Hot water extracts alone contain few triterpenes; alcohol extracts alone contain few beta-glucans. Products made from mycelium grown on grain contain mostly starch from the substrate and little of either, which is the same quality problem that affects the wider medicinal mushroom market.

The Immune Evidence

This is the substantive part of the reishi literature.

Beta-glucans from reishi and related fungi bind pattern recognition receptors on macrophages, dendritic cells and natural killer cells, producing measurable changes in cytokine production and cellular activity in laboratory and animal studies.

In humans, trials in oncology support settings report increased natural killer cell activity, changes in cytokine profiles and improvements in quality of life measures. A Cochrane review of Ganoderma lucidum in cancer concluded that there was insufficient evidence to support it as a first-line option, with some evidence of improved immune parameters and quality of life when used alongside conventional therapy, and it called for better trials. That is an accurate and appropriately narrow conclusion.

Trials in other contexts, including in athletes and in inflammatory conditions, report changes in immune markers with inconsistent clinical significance.

The Sleep Claim

Reishi is marketed in the West primarily as a sleep and calm product, and the evidence for that is the weakest part of its profile.

Rodent studies report that reishi extract increases total sleep time and non-rapid eye movement sleep, with effects that appear to involve the gut microbiome in some work and adenosine and GABAergic mechanisms in others. The effects are reasonably consistent across several animal studies.

Human trials specifically examining sleep with reishi are scarce. Trials in neurasthenia and fatigue report improvements in wellbeing measures that include sleep-related items, and these are not dedicated sleep studies.

So the honest position is: a plausible mechanism, consistent animal data, traditional use as a calming preparation, and almost no direct human sleep evidence. Someone taking reishi for sleep is acting on that basis, which is a legitimate choice made with accurate information rather than a demonstrated effect.

Dose, Form and Quality

• 1.5 to 3 g per day of dual-extracted powder is the common supplemental range, with some trials using higher amounts of specific extracts.
• Standardisation. Look for stated beta-glucan content, not merely polysaccharide content, since the latter includes starch from grain substrate. Triterpene content should also be stated for a dual extract.
• Fruiting body versus mycelium. Fruiting body extracts contain both fractions. Mycelium grown on grain and sold with the substrate is largely starch.
• Timing. Evening, for the calming application. There is no established timing for immune purposes.

Heavy metals. Fungi accumulate heavy metals efficiently from their growing substrate, and independent testing of mushroom supplements has found products exceeding acceptable limits for lead, cadmium and arsenic. Third-party testing is more important in this category than in most.

Safety and Interactions

Reishi is generally well tolerated. Reported effects include dry mouth, throat and nasal dryness, gastrointestinal upset, and dizziness, usually mild and often transient.

Three considerations warrant attention.

• Antiplatelet activity. Reishi has demonstrated antiplatelet effects, and case reports describe bleeding events. This is relevant alongside anticoagulant or antiplatelet therapy and before surgery, where two weeks of separation is prudent.
• Liver. Case reports describe hepatotoxicity associated with reishi powder preparations, including one fatal case. This is rare relative to the volume of use and it is a reason to prefer well-characterised extracts and to stop if liver-related symptoms appear.
• Immunosuppressive therapy. Given documented immunomodulatory activity, use alongside immunosuppressants or in autoimmune conditions warrants clinical input rather than assumption.

Blood pressure and glucose-lowering effects have been reported, which is relevant alongside medication acting in the same direction.